Skip to main content

Table 2 Univariate and multivariate analyses for overall survival (OS) of NSCLC patients

From: Prognostic role of the ABO blood types in Chinese patients with curatively resected non-small cell lung cancer: a retrospective analysis of 1601 cases at a single cancer center

Variable

Median OS (months)

Univariate analysis

Multivariate analysis

HR (95% CI)

P value

HR (95% CI)

P value

Age

 ≥55 years vs. <55 years

67.8 vs. 72.2

1.08 (0.93–1.25)

0.32

–

–

Gender

 Males vs. females

66.5 vs. 76.6

1.17 (1.01–1.37)

0.04

1.03 (0.82–1.28)

0.82

ECOG PS score

 1 vs. 0

 

0.97 (0.90–1.04)

0.36

–

–

Smoking status

 Ever vs. never

64.1 vs. 75.8

1.19 (1.03–1.37)

0.02

1.22 (1.06–1.40)

0.01

Pathology

 Squamous vs. non-squamous

71.4 vs. 69.1

1.00 (0.87–1.16)

0.98

–

–

pT category

 3/4 vs. 1/2

31.0 vs. 79.1

2.06 (1.76–2.41)

<0.01

1.61 (1.35–1.91)

<0.01

pN category

 ≥N1 vs. N0

39.5 vs. NA

2.89 (2.51–3.33)

<0.01

2.42 (1.95–3.00)

<0.01

pTNM stage

 III vs. I–II

34.6 vs. NA

2.83 (2.46–3.25)

<0.01

1.44 (1.16–1.76)

0.01

Surgery type

 Pneumonectomy vs. others

28.2 vs. 72.5

1.80 (1.41–2.30)

<0.01

1.24 (0.96–1.60)

0.11

Chemotherapy

 No vs. yes

57.9 vs. 83.8

1.36 (1.19–1.57)

<0.01

1.31 (1.12–1.53)

<0.01

Blood type

 Group 2 vs. group 1

61.5 vs. 74.9

1.20 (1.04–1.38)

0.01

1.37 (1.10–1.70)

<0.01

  1. CI confidence interval, HR hazard ratio, NA not available. Other abbreviations as in Table 1